Lisa Littner: The Hidden Burden of Prior Authorization in Bleeding Disorder Care
Lisa Littner, Hemophilia Treatment Center Program Manager at Cincinnati, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Haemophilia, adding:
”I am excited to share that my doctoral research on the Burden of Prior Authorization in Bleeding Disorder Specialty Drugs was published this week.
A special thanks to my co-authors, Jami Jones, Trudie Milner, and Elinor Borgert.
Thanks also to the Hemophilia Alliance Foundation for their support and to the Hemophilia Treatment Center staff who participated in this research.”
Title: The Burden of Prior Authorizations in Bleeding Disorder Specialty Drugs
Authors: Lisa Littner, Jami Jones, Trudie Milner, Elinor Borgert
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge